Penciclovir
- Generic Name
- Penciclovir
- Brand Names
- Denavir
- Drug Type
- Small Molecule
- Chemical Formula
- C10H15N5O3
- CAS Number
- 39809-25-1
- Unique Ingredient Identifier
- 359HUE8FJC
- Background
Penciclovir is a synthetic acyclic guanine derivative with antiviral activity used for the treatment of various herpes simplex virus (HSV) infections. Displaying low toxicity and good selectivity, penciclovir is a nucleoside analogue.
- Indication
Used to treat recurrent cold sores on the lips and face from various herpesvirus invections.
- Associated Conditions
- Cold Sore
- Associated Therapies
- -
A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed Brain Tumors (Gliomas).
- First Posted Date
- 2022-04-15
- Last Posted Date
- 2024-05-08
- Lead Sponsor
- University Hospital Heidelberg
- Target Recruit Count
- 406
- Registration Number
- NCT05331521
- Locations
- 🇩🇪
University Hospital Cologne, Neurosurgery, Cologne, Germany
🇩🇪University Hospital Leipzig, Radiation Therapy, Leipzig, Germany
🇩🇪Helios Hospital Schwerin, Neurosurgery, Schwerin, Germany
A Comparative Study of the Efficacy of Penciclovir 10mg/g (1%) Cream in Preventing the Appearance of Classical Lesion in Recurrent Cold Sore Sufferers
- First Posted Date
- 2009-01-12
- Last Posted Date
- 2012-04-20
- Lead Sponsor
- Novartis
- Target Recruit Count
- 126
- Registration Number
- NCT00820534
- Locations
- 🇬🇧
Belfast Health and Social Care Trust, Royal Victoria Hospital, Belfast, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath